oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cost & risk factors when outsourcing API: A case study at AstraZeneca
Örebro University, Örebro University School of Business.
Örebro University, Örebro University School of Business.
2012 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Master thesis in Business Administration, Swedish Business School at Örebro University, fall semester 2011.

 

Authors: Carl Bennerhed, Christoffer Stackell

Tutor: Olle Westin

 

Title: Cost & risk factors when outsourcing API - A case study at AstraZeneca

 

Background: Many pharmaceutical companies have begun, more commonly, to outsource in order to remain competitive, and to reduce the cost of manufacturing. To outsource successfully and gain the advantages, it is important to evaluate risk and cost factors.

 

Research objective: The purpose of this study is to identify and evaluate the factors that affect outsourcing of Active Pharmaceutical Ingredients (API). The results from the literature and theories will be used to compare and identify AstraZeneca’s outsourcing strategies, against the theories. Through comparison and analysis of the results, the research objective is to develop a model that can be used to evaluate risk and cost factors when outsourcing API.

 

Methodology: The foundation for this thesis is based on a qualitative approach. The empirical material is founded upon two semi-structured interviews with AstraZeneca’s Global External Sourcing team.

 

Conclusion: Based on the research, it has been determined that AstraZeneca do not evaluate all the factors that have been identified in the theoretical framework. Therefore, a model is suggested to AstraZeneca, which can assist in the consideration of API outsourcing.

Place, publisher, year, edition, pages
2012. , p. 36
National Category
Business Administration
Identifiers
URN: urn:nbn:se:oru:diva-21619ISRN: ORU-HHS/FEK-AS-2012/0013--SEOAI: oai:DiVA.org:oru-21619DiVA, id: diva2:499874
Subject / course
Företagsekonomi
Uppsok
Social and Behavioural Science, Law
Supervisors
Examiners
Available from: 2012-06-29 Created: 2012-02-13 Last updated: 2017-10-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Stackell, ChristofferBennerhed, Carl
By organisation
Örebro University School of Business
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 131 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf